Xtant Medical Holdings, Inc. - SIC # 3850 -

Ticker Exchange SIC # Website Latest Ticker
XTNT NYSE American 3850 www.xtantmedical.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Xtant Medical Holdings, Inc.

Xtant Medical Announces Secondary Private Sale of Existing Shares by OrbiMed and Preliminary First Quarter 2025 Revenue Growth of 18% to 19% - Apr 16th, 2025 12:05 pm
Xtant Medical Reports Fourth Quarter and Full Year 2024 Financial Results - Mar 6th, 2025 8:05 pm
Xtant Medical to Issue Fourth Quarter and Year End 2024 Financial Results on March 6, 2025 - Feb 28th, 2025 1:00 pm
US Penny Stocks: 3 Picks With Market Caps As Low As $70M - Feb 20th, 2025 8:11 pm
US Penny Stocks To Watch In January 2025 - Jan 22nd, 2025 8:14 pm
3 US Penny Stocks With Market Caps Under $300M - Dec 24th, 2024 8:06 pm
Xtant Medical Reports Third Quarter 2024 Financial Results - Nov 12th, 2024 9:05 pm
Xtant Medical to Attend the 15th Annual Craig-Hallum Alpha Select Conference - Nov 11th, 2024 1:00 pm
Xtant Medical to Issue Third Quarter 2024 Financial Results on November 12, 2024 - Nov 7th, 2024 3:45 pm
Xtant Medical Expands Product Portfolio with the Launch of the Cortera(R) Posterior Fixation System - Sep 23rd, 2024 11:00 am
Xtant Medical Expands Product Portfolio with Launch of its own Viable Bone Matrix, OsteoVive(R) Plus - Sep 18th, 2024 10:00 am
Xtant Medical Announces $5.0 Million Private Placement - Aug 8th, 2024 11:20 am
Xtant Medical to Host Second Quarter 2024 Financial Results Earnings Conference call on August 9, 2024 - Aug 8th, 2024 11:10 am
Xtant Medical Reports Second Quarter 2024 Revenue Growth of 48% - Aug 8th, 2024 11:05 am
Xtant Medical to Present at the Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase - Jul 25th, 2024 12:30 pm
Xtant Medical to Participate in 21st Annual Craig-Hallum Institutional Investor Conference on May 29 - May 22nd, 2024 8:35 pm
Xtant Medical Reports First Quarter 2024 Revenue Growth of 55% and Raises Full Year 2024 Revenue Guidance - May 15th, 2024 8:05 pm
Xtant Medical to Issue First Quarter 2024 Financial Results on May 15, 2024 - May 8th, 2024 12:30 pm
Xtant Medical Announces Launch of SimpliGraft™ and SimpliMax™ for Chronic and Acute Wounds - Apr 30th, 2024 9:00 am